VR/AR in Healthcare Market to Hit $14.9B by 2033

- The U.S. Food and Drug Administration (FDA) is increasingly authorizing VR/AR medical devices, with the list growing to over 100 entries. These approved devices span specialties like radiology, orthopedics, and neurology, including applications for surgical planning, pain management, and physical therapy. - In surgical applications, AR can provide surgeons with "X-ray vision" by overlaying 3D models of a patient's anatomy onto their body in real-time. Studies have shown that VR-trained surgeons make up to 50% fewer critical errors and can reduce training time by as much as 75%. - Venture capital and private equity investment are fueling innovation in the sector. Notable funding includes Proprio's $43 million for its AI-driven surgical navigation platform and Osso VR's $14 million to advance its VR-based surgical training modules. - The market is populated by both major tech companies and specialized startups. Key players include Microsoft (HoloLens), CAE Healthcare, GE Healthcare, and Siemens Healthineers, who are actively developing and deploying these technologies. - Beyond the operating room, VR is being used for at-home patient care, including rehabilitation and mental health treatment for conditions like PTSD and anxiety. The patient/home user segment is projected to grow significantly as these applications become more common. - The health and fitness app sector is a significant growth area, using VR/AR to create gamified, immersive workouts. Apps like Supernatural and FitXR offer virtual coaching and interactive environments, turning exercise into a more engaging experience. - Hardware, including head-mounted displays and smart glasses, currently represents the largest share of the market, accounting for over 67% of revenue. Companies like Vuzix are partnering with telemedicine providers to deploy AR smart glasses for remote healthcare solutions.